CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Savaid Medical School, University of Chinese Academy of Sciences, Beijing, China.
Autophagy. 2024 Jul;20(7):1483-1504. doi: 10.1080/15548627.2024.2321831. Epub 2024 Mar 4.
Infectious diseases, such as (Mtb)-caused tuberculosis (TB), remain a global threat exacerbated by increasing drug resistance. Host-directed therapy (HDT) is a promising strategy for infection treatment through targeting host immunity. However, the limited understanding of the function and regulatory mechanism of host factors involved in immune defense against infections has impeded HDT development. Here, we identify the ubiquitin ligase (E3) TRIM27 (tripartite motif-containing 27) as a host protective factor against Mtb by enhancing host macroautophagy/autophagy flux in an E3 ligase activity-independent manner. Mechanistically, upon Mtb infection, nuclear-localized TRIM27 increases and functions as a transcription activator of (transcription factor EB). Specifically, TRIM27 binds to the promoter and the TFEB transcription factor CREB1 (cAMP responsive element binding protein 1), thus enhancing CREB1- promoter binding affinity and promoting CREB1 transcription activity toward , eventually inducing autophagy-related gene expression as well as autophagy flux activation to clear the pathogen. Furthermore, TFEB activator 1 can rescue TRIM27 deficiency-caused decreased autophagy-related gene transcription and attenuated autophagy flux, and accordingly suppressed the intracellular survival of Mtb in cell and mouse models. Taken together, our data reveal that TRIM27 is a host defense factor against Mtb, and the TRIM27-CREB1-TFEB axis is a potential HDT-based TB target that can enhance host autophagy flux.: ATG5: autophagy related 5; BMDMs: bone marrow-derived macrophages; CFU: colony-forming unit; ChIP-seq: chromatin immunoprecipitation followed by sequencing; CREB1: cAMP responsive element binding protein 1; CTSB: cathepsin B; E3: ubiquitin ligase; EMSA: electrophoretic mobility shift assay; HC: healthy control; HDT: host-directed therapy; LAMP: lysosomal associated membrane protein; MAP1LC3/LC3: microtubule associated protein 1 light chain 3; MCOLN1: mucolipin TPR cation channel 1; Mtb: ; NLS: nuclear localization signal; PBMCs: peripheral blood mononuclear cells; PRKA/PKA: protein kinase cAMP-activated; qRT-PCR: quantitative real-time PCR; RFP: RET finger protein; TB: tuberculosis; TBK1: TANK binding kinase 1; TFEB: transcription factor EB; TRIM: tripartite motif; TSS: transcription start site; ULK1: unc-51 like autophagy activating kinase 1.
传染病,如由结核分枝杆菌(Mtb)引起的结核病(TB),仍然是一个全球性的威胁,而且耐药性的增加使情况更加恶化。宿主导向治疗(HDT)是一种通过靶向宿主免疫来治疗感染的有前途的策略。然而,由于对宿主中参与免疫防御感染的因子的功能和调控机制的了解有限,HDT 的发展受到了阻碍。在这里,我们通过一种非 E3 连接酶活性依赖的方式,确定泛素连接酶(E3)TRIM27(三肽重复含 27 个氨基酸)作为一种宿主保护性因子,抵抗 Mtb,增强宿主巨自噬/自噬流。在机制上,在 Mtb 感染后,核定位的 TRIM27 增加,并作为 (转录因子 EB)的转录激活因子发挥作用。具体来说,TRIM27 结合到 启动子和 TFEB 转录因子 CREB1(cAMP 反应元件结合蛋白 1),从而增强 CREB1-启动子结合亲和力,并促进 CREB1 对 的转录活性,最终诱导自噬相关基因表达和自噬流激活,以清除病原体。此外,TFEB 激活剂 1 可以挽救 TRIM27 缺陷引起的自噬相关基因转录减少和自噬流减弱,并相应地抑制细胞和小鼠模型中 Mtb 的体内存活。总之,我们的数据表明,TRIM27 是一种针对 Mtb 的宿主防御因子,TRIM27-CREB1-TFEB 轴是一种潜在的基于 HDT 的抗结核靶点,可增强宿主自噬流。:ATG5:自噬相关 5;BMDMs:骨髓来源的巨噬细胞;CFU:集落形成单位;ChIP-seq:染色质免疫沉淀结合测序;CREB1:cAMP 反应元件结合蛋白 1;CTSB:组织蛋白酶 B;E3:泛素连接酶;EMSA:电泳迁移率变动分析;HC:健康对照;HDT:宿主导向治疗;LAMP:溶酶体相关膜蛋白;MAP1LC3/LC3:微管相关蛋白 1 轻链 3;MCOLN1:粘蛋白 TPR 阳离子通道 1;Mtb:结核分枝杆菌;NLS:核定位信号;PBMCs:外周血单核细胞;PRKA/PKA:蛋白激酶 cAMP 激活;qRT-PCR:定量实时 PCR;RFP:RET 手指蛋白;TB:结核病;TBK1:TANK 结合激酶 1;TFEB:转录因子 EB;TRIM:三肽重复;TSS:转录起始位点;ULK1:UNC-51 样自噬激活激酶 1。